CPT® Code 0342T

A therapeutic apheresis procedure is utilized to selectively delipidate high-density lipoprotein (HDL) cholesterol and subsequently reinfuse the treated plasma back into the patient. This advanced medical intervention is particularly relevant for patients experiencing acute coronary syndrome, which may present as unstable angina or non-ST-segment elevation myocardial infarction. The process of apheresis involves the extraction of whole blood from the patient, which is then subjected to a centrifugation technique that separates the blood components. During this procedure, the alpha HDL is transformed into a pre-beta-like HDL, a variant that is more effective in facilitating the removal of lipids from arterial plaque. The conversion to pre-beta-like HDL is significant as it enhances the transport of cholesterol to the liver, thereby contributing to a reduction in atherosclerosis within the blood vessels. This reduction in atherosclerosis is crucial for lowering the risk of developing further cardiovascular complications. The procedure begins with establishing venous access, after which the patient is connected to a specialized machine designed for apheresis. This machine not only separates the blood cells but also incorporates organic solvents to effectively delipidate the HDL. Finally, the modified plasma, now containing the altered HDL, is reinfused back into the patient, completing the therapeutic process.